骨形态发生蛋白-2通过Smad1和p65信号通路促进破骨细胞介导的骨溶解
该体外生物学研究从C57BL/6J小鼠分离骨髓来源巨噬细胞(BMMs),用M-CSF和RANKL诱导破骨细胞分化,通过骨片共培养及RT-PCR、Western blot、共聚焦显微镜和免疫共沉淀检测。结果显示BMP-2以浓度依赖方式增强破骨细胞分化与骨吸收,高浓度BMP-2上调p-Smad1/5/8和p65磷酸化、促进IκBα降解,并通过BMP受体II与RANK偶联诱导破骨细胞分化。作者认为高浓度BMP-2可能通过BMP经典通路与NF-κB通路间交互作用促进RANKL诱导的破骨前体细胞分化。
要点
- BMP-2以浓度依赖方式增强破骨细胞介导的骨吸收。
- 高浓度BMP-2上调p-Smad1/5/8和p65磷酸化并促进IκBα降解。
- BMP-2通过BMP受体II与RANK偶联诱导破骨细胞分化。
核心结论
- 高浓度BMP-2通过促进RANKL诱导的破骨前体细胞分化增强破骨细胞介导的骨吸收,可能通过介导BMP经典通路与NF-κB信号通路间的交互作用实现。
研究设计与样本
- 体外生物学研究:从C57BL/6J小鼠分离骨髓来源巨噬细胞(BMMs),用巨噬细胞集落刺激因子(M-CSF)和核因子κB受体活化因子配体(RANKL)诱导破骨细胞分化。
- 通过BMMs与骨片共培养进行体外骨吸收实验。
- 采用逆转录聚合酶链反应、Western blot、共聚焦显微镜和免疫共沉淀定量检测BMP经典通路和NF-κB信号因子及其在信号转导中的相互作用。
主要发现
- BMP-2以浓度依赖方式诱导破骨细胞分化,从而增强破骨细胞介导的骨吸收。
- 高浓度BMP-2显著上调BMP信号因子p-Smad1/5/8和NF-κB下游因子p65的磷酸化,并促进IκBα降解。
- BMP-2通过BMP受体II与RANK之间的偶联诱导破骨细胞分化。
关键数值与推荐
- 证据等级:N/A。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: An in vitro biological study. OBJECTIVE: The aim of this study was to explore the role of bone morphogenetic protein-2 (BMP-2) in the regulation of osteoclast-mediated osteolysis, and the possible mechanism involving BMP-2 and nuclear factor-kappa B (NF-κB) signaling pathways. SUMMARY OF BACKGROUND DATA: Recombinant human BMP-2 (rhBMP-2) has been approved as a therapeutic agent in spinal fusion and bone defect repair. However, its efficacy and clinical application are limited by associated complications including osteoclast-mediated bone resorption. The mechanism of BMP-2-induced osteolysis remains unknown. METHODS: Bone marrow-derived macrophages (BMMs) were isolated from C57BL/6J mice and cultured with macrophage colony-stimulating factor (M-CSF) and receptor activator for nuclear factor-κB Ligand (RANKL) to induce osteoclast differentiation. An in vitro bone resorption assay was performed by co-culturing BMMs and bone slides. The expression of BMP canonical and NF-κB signaling factors and their interaction during signal transduction were quantitated by reverse transcription polymerase chain reaction, Western blot analysis, confocal microscopy, and co-immunoprecipitation. RESULTS: BMP-2 enhanced osteoclast-mediated bone resorption via inducing osteoclast differentiation in a concentration-dependent manner. In addition, a high concentration of BMP-2 significant upregulated phosphorylation of BMP signaling factors p-Smad1/5/8 and NF-κB downstream factor p65, and promoted the degeneration of IκBα. In addition, BMP-2 induced osteoclast differentiation through coupling between BMP receptor II and RANK. CONCLUSION: High concentrations of BMP-2 enhanced osteoclast-mediated bone resorption by promoting RANKL-induced pre-osteoclast differentiation, probably by mediating the cross-talk between BMP canonical and NF-κB signaling pathways.Level of Evidence: N/A.
引用
- Miao X, Yuan J, Wu J, et al. Bone Morphogenetic Protein-2 Promotes Osteoclasts-mediated Osteolysis via Smad1 and p65 Signaling Pathways. Spine (Phila Pa 1976). 2021. PMID: 33156278. doi:10.1097/BRS.0000000000003770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。